Clinical Trial

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Study acronym: ADVANCE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.
Protocol Amendment History 2 changes
notable Trial sites expanded: 50 -> 104 locations 2026-07-21
notable Trial sites expanded: 41 -> 50 locations 2026-04-21
Trial Details
NCT Number NCT06672549
Lead Sponsor Eli Lilly and Company
Conditions Obesity, Overweight
Enrollment 125 participants
Start Date 2024-11-18
Primary Completion 2027-02 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-20